IL4I1+ Macrophage Accumulation in Advanced Cutaneous T-Cell Lymphomas Suggests a Role in Tumor Immune Escape

This publication has 11 references indexed in Scilit:

• Conditional IL4I1 Inactivation Triggers Tumor-Associated Macrophage Reprogramming and CD8+ T-cell Reactivation to Control Melanoma Progression
  Cancer Immunology Research, 2026
• Spatial transcriptomics of progression gene signature and tumor microenvironment leading to progression in mycosis fungoides
  Blood Advances, 2025
• From Molecules to Microbes: Tracing Cutaneous T-Cell Lymphoma Pathogenesis through Malignant Inflammation
  Journal of Investigative Dermatology, 2024
• Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma
  Cancer Letters, 2022
• IL4I1 binds to TMPRSS13 and competes with SARS-CoV-2 spike
  Frontiers in Immunology, 2022
• Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma
  Nature Communications, 2022
• What role for AHR activation in IL4I1-mediated immunosuppression ?
  OncoImmunology, 2021
• IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression
  Cell, 2020
• Immunohistochemical Features of Indoleamine 2,3-Dioxygenase (IDO) in Various Types of Lymphoma: A Single Center Experience
  Diagnostics, 2020
• Lack of Suppressive CD4+CD25+FOXP3+ T Cells in Advanced Stages of Primary Cutaneous T-Cell Lymphoma
  Journal of Investigative Dermatology, 2006